StataDX is building a next-generation blood diagnostic platform focused on neurology, with a breakthrough portable "Liquid MRI" for the brain. At the core of their technology is eRapid, a low-cost, affinity-based electrochemical sensing platform that can simultaneously detect a broad range of biomarkers with high sensitivity and selectivity in complex biological fluids, using as little as a single drop of blood. This platform enable at-home monitoring of neurodegenerative conditions such as Multiple Sclerosis and Alzheimer's as well as rapid triage for acute neurological conditions like Traumatic Brain Injury. In neurology and beyond, their mission is to empower clinicians to deliver quicker, more effective, safer, and more personalized care, and researchers to accelerate medical discovery.
Thursday, October 12, 2023
Sanjay Sharma Timilsina, Ph.D., is the Lead Scientist at StataDx, a start-up from Harvard’s Wyss Institute, focused on developing and commercializing cost-effective and highly sensitive point-of-care devices for Neurological conditions. Sanjay received his Doctoral degree in Chemistry and Biochemistry from the University of Texas at El Paso with Best Dissertation and Graduate award for Academic and Research Excellence. Sanjay has a decade of experience in Assay development and validation in microfluidic medical devices which enabled successful development of a multiplexed, electrochemical sensing technology, “eRapid” that has been licensed by Wyss Institute to StataDx. Sanjay is utilizing his experience under both academic and industrial settings to develop a near-patient diagnostic platform to support biomarker-guided therapeutic strategies for patients suffering from chronic conditions including Alzheimer’s, Multiple Sclerosis, and Traumatic Brain Injury at StataDx.
One Piece of Advice to Venturing@Harvard
"The only thing you cannot buy is more time so stop waiting and take the risk to bring your ideas and what you are good at to life or bench today. Be your own critic and challenge yourself all the time. Don’t be smitten by your idea but the problem you are solving and be open to new ideas."